All About Covid-19 in Brief

Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share this content! On (X network) By

All About Covid-19 in Brief Publisher

Naserghandi A¹ ; Allameh SF² ; Saffarpour R¹

Show Affiliations

1. Shahid Beheshti University of Medical Sciences, Iran
2. Tehran University of Medical Sciences, Iran

Source: New Microbes and New Infections Published:2020

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)

2. Classification of the Present Pharmaceutical Agents Based on the Possible Effective Mechanism on the Covid-19 Infection, DARU# Journal of Pharmaceutical Sciences (2020)

3. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)

4. Covid-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. an International Society of Addiction Medicine Practice and Policy Interest Group Position Paper, Basic and Clinical Neuroscience (2020)

5. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)

6. Covid-19: Transmission, Prevention, and Potential Therapeutic Opportunities, Clinica Chimica Acta (2020)

7. Pregnant Women and Infants Against the Infection Risk of Covid-19: A Review of Prenatal and Postnatal Symptoms, Clinical Diagnosis, Adverse Maternal and Neonatal Outcomes, and Available Treatments, Archives of Gynecology and Obstetrics (2022)

8. Computational Drug Discovery and Repurposing for the Treatment of Covid-19: A Systematic Review, Bioorganic Chemistry (2021)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (11)

Ladan Abbasian (3)

Other Related Docs

9. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)

10. The Significance of Bioengineered Nanoplatforms Against Sars-Cov-2: From Detection to Genome Editing, Life Sciences (2021)

11. Covid-19 Infection and Liver Injury: Clinical Features, Biomarkers, Potential Mechanisms, Treatment, and Management Challenges, World Journal of Clinical Cases (2021)

12. The Clinical Value of Two Combination Regimens in the Management of Patients Suffering From Covid-19 Pneumonia: A Single Centered, Retrospective, Observational Study, DARU# Journal of Pharmaceutical Sciences (2020)

13. Towards Treatment Planning of Covid-19: Rationale and Hypothesis for the Use of Multiple Immunosuppressive Agents: Anti-Antibodies, Immunoglobulins, and Corticosteroids, International Immunopharmacology (2020)

14. Immunopathological Similarities Between Covid-19 and Influenza: Investigating the Consequences of Co-Infection, Microbial Pathogenesis (2021)

15. Nanotheranostics Against Covid-19: From Multivalent to Immune-Targeted Materials, Journal of Controlled Release (2020)

16. State-Of-The-Art of Nanodiagnostics and Nanotherapeutics Against Sars-Cov-2, ACS Applied Materials and Interfaces (2021)

17. Current Treatments and Therapeutic Options for Covid-19 Patients: A Systematic Review, Infectious Disorders - Drug Targets (2022)

18. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)

19. An Overview on the Treatments and Prevention Against Covid-19, Virology Journal (2023)

20. The Effect of Exogenous Surfactant on Moderate and Severe Stages of Covid-19 Induced Ards: The Pilot Study of a Clinical Trial, Iranian Journal of Pharmaceutical Research (2021)

21. A Review of Covid-19: The Main Ways of Transmission and Some Prevention Solutions, Clinical Symptoms, More Vulnerable Human Groups, Risk Factors, Diagnosis, and Treatment, Journal of Environmental Treatment Techniques (2020)

22. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)

23. Pathophysiology of Covid-19 Infection: What Is the Novel Coronavirus (Sars-Cov-2) Doing to Body? a Comprehensive Systematic Review, Reviews and Research in Medical Microbiology (2021)

24. Mesenchymal Stem Cell Therapies for Covid-19: Current Status and Mechanism of Action, Life Sciences (2020)

25. Sars-Cov-2: A Comprehensive Review From Pathogenicity of the Virus to Clinical Consequences, Journal of Medical Virology (2020)

26. Therapeutic and Diagnostic Applications of Nanoparticles in the Management of Covid-19: A Comprehensive Overview, Virology Journal (2022)

27. Possible Overlap of Laboratory Findings Between Patients With Covid-19 and Substance Use Disorders, Archives of Clinical Infectious Diseases (2020)

28. Sars-Cov-2 and Covid-19, Basic and Clinical Aspects of the Human Pandemic: A Review, Iranian Journal of Public Health (2021)

29. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)

30. Sudden Hearing Loss and Coronavirus Disease 2019: The Role of Corticosteroid Intra-Tympanic Injection in Hearing Improvement, Journal of Laryngology and Otology (2021)

31. Improvement of the Inactivated Sars-Cov-2 Vaccine Potency Through Formulation in Alum/Naloxone Adjuvant; Robust T Cell and Anti-Rbd Igg Responses, Iranian Journal of Basic Medical Sciences (2022)

32. The Role of Mesenchymal Stromal Cells in Immune Modulation of Covid-19: Focus on Cytokine Storm, Stem Cell Research and Therapy (2020)

33. Prevalence of Covid-19-Like Symptoms Among People Living With Hiv, and Using Antiretroviral Therapy for Prevention and Treatment, Current HIV Research (2020)

34. Prevention of Covid-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions, Advances in Experimental Medicine and Biology (2021)

35. Remdesivir: A Beacon of Hope From Ebola Virus Disease to Covid-19, Reviews in Medical Virology (2020)

36. Auxiliary Role of Mesenchymal Stem Cells As Regenerative Medicine Soldiers to Attenuate Inflammatory Processes of Severe Acute Respiratory Infections Caused by Covid-19, Cell and Tissue Banking (2020)

37. Novel Therapeutic Approaches for Treatment of Covid-19, Journal of Molecular Medicine (2020)

38. Emerging Advances of Nanotechnology in Drug and Vaccine Delivery Against Viral Associated Respiratory Infectious Diseases (Varid), International Journal of Molecular Sciences (2021)

39. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)

40. Immune Responses and Pathogenesis of Sars-Cov-2 During an Outbreak in Iran: Comparison With Sars and Mers, Reviews in Medical Virology (2020)

41. The Situation of Small Molecules Targeting Key Proteins in Combatting Sars-Cov-2: Synthesis, Metabolic Pathway, Mechanism of Action, and Potential Therapeutic Applications, Mini-Reviews in Medicinal Chemistry (2022)

42. Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview, International Immunopharmacology (2021)

43. Nanobionics: From Plant Empowering to the Infectious Disease Treatment, Journal of Controlled Release (2022)

44. Immune-Based Therapy for Covid-19, Advances in Experimental Medicine and Biology (2021)

45. Covid-19: Review of a 21St Century Pandemic From Etiology to Neuro-Psychiatric Implications, Journal of Alzheimer's Disease (2020)

46. Therapeutic Potentials and Candidates for Covid-19, Iranian Journal of Science (2023)

47. Febuxostat Therapy in Outpatients With Suspected Covid-19: A Clinical Trial, International Journal of Clinical Practice (2020)

48. Spatio-Temporal Analysis of Covid-19 Incidence Rate Using Gis: A Case Study—Tehran Metropolitan, Iran, GeoJournal (2022)

49. Can Anti-Parasitic Drugs Help Control Covid-19?, Future Virology (2022)

50. The Prophylaxis and Treatment Potential of Supplements for Covid-19, European Journal of Pharmacology (2020)

Style	Citing Format
MLA	Naserghandi A, Allameh SF, Saffarpour R. "All About Covid-19 in Brief." New Microbes and New Infections, vol. 35, no. , 2020, pp. -.
APA	Naserghandi A, Allameh SF, Saffarpour R (2020). All About Covid-19 in Brief. New Microbes and New Infections, 35(), -.
Chicago	Naserghandi A, Allameh SF, Saffarpour R. "All About Covid-19 in Brief." New Microbes and New Infections 35, no. (2020): -.
Harvard	Naserghandi A, Allameh SF, Saffarpour R (2020) 'All About Covid-19 in Brief', New Microbes and New Infections, 35(), pp. -.
Vancouver	Naserghandi A, Allameh SF, Saffarpour R. All About Covid-19 in Brief. New Microbes and New Infections. 2020;35():-.
BibTex	@article{ author = {Naserghandi A and Allameh SF and Saffarpour R}, title = {All About Covid-19 in Brief}, journal = {New Microbes and New Infections}, volume = {35}, number = {}, pages = {-}, year = {2020} }
RIS	TY - JOUR AU - Naserghandi A AU - Allameh SF AU - Saffarpour R TI - All About Covid-19 in Brief JO - New Microbes and New Infections VL - 35 IS - SP - EP - PY - 2020 ER -